NMOSD Part 2 - The importance and tools for monitoring NMOSD, and signs, symptoms and evaluation of disease activity
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
MS & Immune DisordersKappa Free Light Chains in the 2024 McDonald Criteria: What Neurologists Need to Know
Maria Alice Vieira Willrich, PhDMaria Alice Vieira Willrich, PhD
MS & Immune DisordersMS Minute: Emerging Myelin Repair Therapies in Multiple Sclerosis
Mahtab Moniri, MPhil; Meher Sabharwal, BA (Hons)Mahtab Moniri, MPhil; Meher Sabharwal, BA (Hons)
MS & Immune DisordersMS Minute: Chimeric Antigen Receptor T-Cell Therapy for Progressive Multiple Sclerosis: Rationale, Evidence, and Therapeutic Potential
Sarah Conway, MD; Kristin Galetta, MD, MSeDSarah Conway, MD; Kristin Galetta, MD, MSeD
Alzheimer Disease & DementiasSpecial Report: 2025 Neurology FDA Drug & Device Approvals & Clearances




